175 related articles for article (PubMed ID: 38410130)
1. Discovery of a small-molecule NDR1 agonist for prostate cancer therapy.
Bai Y; Sui X; Xuan Z; Du Y; Fu M; Zheng Z; Yang K; Xu C; Liu Y; Liu B; Zhong M; Zhang Z; Zheng J; Hu X; Zhang L; Sun H; Shao C
Front Pharmacol; 2024; 15():1367358. PubMed ID: 38410130
[TBL] [Abstract][Full Text] [Related]
2. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
3. A review of nuclear Dbf2-related kinase 1 (NDR1) protein interaction as promising new target for cancer therapy.
Lu J; Feng Y; Yu D; Li H; Li W; Chen H; Chen L
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129188. PubMed ID: 38184050
[TBL] [Abstract][Full Text] [Related]
4. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of NDR1 contributes to metastasis of prostate cancer cells via activating epithelial-mesenchymal transition.
Yue J; Sun H; Liu S; Yu F; Wang S; Wang F; Shen R; Zhu F; Zhang L; Shao C
Cancer Med; 2018 Jul; 7(7):3200-3212. PubMed ID: 29733518
[TBL] [Abstract][Full Text] [Related]
6. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
[TBL] [Abstract][Full Text] [Related]
7. Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.
Cheng Q; Butler W; Zhou Y; Zhang H; Tang L; Perkinson K; Chen X; Jiang XS; McCall SJ; Inman BA; Huang J
Eur Urol; 2022 May; 81(5):446-455. PubMed ID: 35058087
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Dbf2-related Kinase 1 functions as tumor suppressor in glioblastoma by phosphorylation of Yes-associated protein.
Chen B; Liu B; Yu T; Han YF; Wu C; Wang ZY
Chin Med J (Engl); 2021 Aug; 134(17):2054-2065. PubMed ID: 34343153
[TBL] [Abstract][Full Text] [Related]
9. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
10. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Roles of NDR1/2 in Infection and Inflammation.
Ye X; Ong N; An H; Zheng Y
Front Immunol; 2020; 11():534. PubMed ID: 32265942
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.
Sun F; Wu K; Yao Z; Mu X; Zheng Z; Sun M; Wang Y; Liu Z; Zhu Y
Aging (Albany NY); 2020 Jun; 12(12):11500-11516. PubMed ID: 32554858
[TBL] [Abstract][Full Text] [Related]
15. NDR1/STK38 potentiates NF-κB activation by its kinase activity.
Shi DD; Shi H; Lu D; Li R; Zhang Y; Zhang J
Cell Biochem Funct; 2012 Dec; 30(8):664-70. PubMed ID: 22674419
[TBL] [Abstract][Full Text] [Related]
16. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K
Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Dbf2-related protein kinases (NDRs) in isolated cardiac myocytes and the myocardium: activation by cellular stresses and by phosphoprotein serine-/threonine-phosphatase inhibitors.
Fuller SJ; Pikkarainen S; Tham el L; Cullingford TE; Molkentin JD; Cornils H; Hergovich A; Hemmings BA; Clerk A; Sugden PH
Cell Signal; 2008 Aug; 20(8):1564-77. PubMed ID: 18555663
[TBL] [Abstract][Full Text] [Related]
18. Threonine 74 of MOB1 is a putative key phosphorylation site by MST2 to form the scaffold to activate nuclear Dbf2-related kinase 1.
Hirabayashi S; Nakagawa K; Sumita K; Hidaka S; Kawai T; Ikeda M; Kawata A; Ohno K; Hata Y
Oncogene; 2008 Jul; 27(31):4281-92. PubMed ID: 18362890
[TBL] [Abstract][Full Text] [Related]
19. Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo.
Liu J; Zhang R; Su T; Zhou Q; Gao L; He Z; Wang X; Zhao J; Xing Y; Sun F; Cai W; Wang X; Han J; Qin R; Désaubry L; Han B; Chen W
J Exp Clin Cancer Res; 2023 May; 42(1):128. PubMed ID: 37210546
[TBL] [Abstract][Full Text] [Related]
20. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
